- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 106.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 100.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 100.52M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$39.5K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$33.87K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $100 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $0 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $0 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9.77K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$62.15K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$39.95K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$8.57K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $507.83K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $63.65K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $67.6K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.5K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $517.6K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.5K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $66.77K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $28.81K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$119.31K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$31.38K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$119.31K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$31.38K |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |